IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Kenneth E. De Paul who wrote (273)	1/8/1997 11:14:00 PM
From: Don Cheng	of 1762

The price range of a stock depends on whether the company can meet analyst's expectation. For company like IDEC which does not have any revenue generated by it's own product, the price really depends on if the company can get C2B8 approved by the FDA this year. If so, you will see the price move up to beyond the current price range when the company files the submission later this year. If you have confidence on this company, it is really a good time to accumulate the stock, just like the other folks did in the last couple days. Don

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next